首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of oncology pharmacy practice

缩写:J ONCOL PHARM PRACT

ISSN:1078-1552

e-ISSN:1477-092X

IF/分区:1.3/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引3037条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Masami Tsuchiya,Manit Saeteaw,Suphat Subongkot et al. Masami Tsuchiya et al.
Introduction: This study aimed to evaluate the participants' comfort in understanding research papers written in English and discussing such research in English via an Asian online journal club. ...
Kelly J Gaffney,Theresa A Urban,Mariana Lucena et al. Kelly J Gaffney et al.
Busulfan-based conditioning regimens are associated with serious toxicities and literature reports increased risk of toxicities when daily area under the curve concentrations exceed 6000 µM-minute. We implemented real time pharmacokinetic-...
Laurence Bonhomme-Faivre,Valentina Guarino,Srimanta C Misra Laurence Bonhomme-Faivre
Introduction: Nivolumab, the monoclonal antibody inhibitor of programmed cell death protein 1, enhances the T-cell response, including anti-tumour responses, by blocking the attachment of programmed death-ligand 1 and pro...
Latifa Khelifa,Imen Ben Amor,Olfa Kassar et al. Latifa Khelifa et al.
Introduction: Tyrosine kinase inhibitor had changed the prognosis of chronic myeloid leukemia (CML) and the overall survival had reached 95%. Unfortunately, adverse events (AEs) remain an obstacle to following successful ...
Alexandre Marineau,Catherine St-Pierre,Roxanne Lessard-Hurtubise et al. Alexandre Marineau et al.
Background: Outpatients treated with oral anti-cancer drugs, including selective cyclin-dependent kinase 4/6 inhibitors (CDK4/6i), may benefit from a pharmacy practice setting adapted to support proper oral anti-cancer dr...
Muhammed Yunus Bektay,Zehra Seker,Hatice Kubra Eke et al. Muhammed Yunus Bektay et al.
Introduction: One of the most intriguing situations for healthcare providers is cancer therapy. Drug-drug interactions (DDIs) account for 20-30% of all adverse effects. Cancer patients are more likely to have potential-DD...
Azieb Ogbaghebriel,Majed Alshamrani,Alnada Ibrahim et al. Azieb Ogbaghebriel et al.
Background: Chemotherapy drug handling and occupational exposure are topics of concern for a variety of oncology health care professionals. Inappropriate handling can pose health risks to practitioners particularly, those...
Rachel V Hatch,Craig W Freyer,Alison Carulli et al. Rachel V Hatch et al.
Introduction: Hemorrhagic cystitis can commonly occur following an allogeneic hematopoietic cell transplant and treatment options are currently limited. Pentosan polysulfate, a heparin-like, sulfated polysaccharide, is us...
Kirollos S Hanna,Andrew Fijalka,Ian Watson et al. Kirollos S Hanna et al.
Objective: Chronic lymphocytic leukemia and small lymphocytic lymphoma remain the most prevalent adult leukemia in Western countries. Novel therapeutics have established long-term efficacy and have changed the landscape i...